vTv Therapeutics Inc.
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $1.0M | $0 | $0 | $0 | $0 | $9.0K | $0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $3.4M | $2.6M | $2.1M | $2.8M | $4.7M | $3.9M | $4.0M | $3.1M |
| SG&A Expense | $3.7M | $4.0M | $2.6M | $2.5M | $3.3M | $3.5M | $2.4M | $2.6M |
| Operating Income | $-7.2M | $-5.6M | $-4.7M | $-5.4M | $-8.0M | $-7.4M | $-6.3M | $-5.7M |
| Operating Margin | — | -562.7% | — | — | — | — | -70,477.8% | — |
| Interest Expense | — | — | $7.0K | $4.0K | $2.0K | $0 | $6.0K | $8.0K |
| Pretax Income | $-6.4M | $-5.9M | $-4.4M | $-8.5M | $-7.2M | $-5.8M | $-6.1M | $-5.5M |
| Income Tax Expense | $0 | $100.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-5.2M | $-4.9M | $-3.5M | $-6.7M | $-5.6M | $-4.5M | $-4.7M | $-4.3M |
| Net Margin | — | -486.5% | — | — | — | — | -52,722.2% | — |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Basic) | — | — | — | — | — | — | — | — |
| Shares Outstanding (Diluted) | — | — | — | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |